ASX - By Stock
|
PAB |
Re:
Ann: Appendix 4C - Quarterly - 31 March 2024
|
|
pipjon
|
20 |
4.8K |
2 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
20
|
4.8K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Patent Granted in Israel for RECCE Anti-Infectives
|
|
pipjon
|
8 |
3.1K |
5 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
8
|
3.1K
|
5
|
|
ASX - By Stock
|
EMV |
Re:
Introducing Zeus - a perfect partner for our Gen 2 device.
|
|
pipjon
|
3 |
1.9K |
0 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
3
|
1.9K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bonus Options Prospectus
|
|
pipjon
|
226 |
53K |
2 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
226
|
53K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
ASH2023 - Sheba 2.0
|
|
pipjon
|
156 |
50K |
13 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
156
|
50K
|
13
|
|
ASX - By Stock
|
RCE |
Re:
How do you get access to Recce 327
|
|
pipjon
|
17 |
6.0K |
13 |
07/10/23 |
07/10/23 |
ASX - By Stock
|
17
|
6.0K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Shows Broad Anti-Cancer Activity in Cancer Cells
|
|
pipjon
|
218 |
71K |
2 |
24/09/23 |
24/09/23 |
ASX - By Stock
|
218
|
71K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Shows Broad Anti-Cancer Activity in Cancer Cells
|
|
pipjon
|
218 |
71K |
2 |
23/09/23 |
23/09/23 |
ASX - By Stock
|
218
|
71K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Shows Broad Anti-Cancer Activity in Cancer Cells
|
|
pipjon
|
218 |
71K |
5 |
23/09/23 |
23/09/23 |
ASX - By Stock
|
218
|
71K
|
5
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Placement and Entitlement Offer
|
|
pipjon
|
101 |
34K |
11 |
11/09/23 |
11/09/23 |
ASX - By Stock
|
101
|
34K
|
11
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Additional Positive Patient Cases - Special Access Scheme
|
|
pipjon
|
24 |
7.4K |
16 |
04/09/23 |
04/09/23 |
ASX - By Stock
|
24
|
7.4K
|
16
|
|
ASX - By Stock
|
RAC Biotech |
Re:
Large BUY - ex insider/ ex CSO / new consultant - Dr Tillett
|
|
pipjon
|
143 |
51K |
2 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
143
|
51K
|
2
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Latest Imaging and Clinical Trial Insights
|
|
pipjon
|
46 |
14K |
1 |
25/08/23 |
25/08/23 |
ASX - By Stock
|
46
|
14K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Clarification - 5x Higher Concentration in Urine & Plasma
|
|
pipjon
|
21 |
5.7K |
1 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
21
|
5.7K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Phase I Clinical Trial Data Review Complete
|
|
pipjon
|
31 |
8.1K |
2 |
19/07/23 |
19/07/23 |
ASX - By Stock
|
31
|
8.1K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Phase I Clinical Trial Data Review Complete
|
|
pipjon
|
31 |
8.1K |
12 |
19/07/23 |
19/07/23 |
ASX - By Stock
|
31
|
8.1K
|
12
|
|
ASX - By Stock
|
RAC |
Re:
Ann: H1 2023 Preclinical and Clinical Programs Update
|
|
pipjon
|
119 |
41K |
7 |
07/07/23 |
07/07/23 |
ASX - By Stock
|
119
|
41K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: H1 2023 Preclinical and Clinical Programs Update
|
|
pipjon
|
119 |
41K |
32 |
07/07/23 |
07/07/23 |
ASX - By Stock
|
119
|
41K
|
32
|
|
ASX - By Stock
|
RAC |
Re:
Ann: H1 2023 Preclinical and Clinical Programs Update
|
|
pipjon
|
119 |
41K |
82 |
07/07/23 |
07/07/23 |
ASX - By Stock
|
119
|
41K
|
82
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Leadership Changes
|
|
pipjon
|
559 |
178K |
30 |
24/03/23 |
24/03/23 |
ASX - By Stock
|
559
|
178K
|
30
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Further Positive Preclinical Results for ARG-007 In HIE
|
|
pipjon
|
15 |
4.5K |
2 |
29/09/22 |
29/09/22 |
ASX - By Stock
|
15
|
4.5K
|
2
|
|
ASX - By Stock
|
MNS |
Re:
Ann: Nachu Graphite Project BFS Update
|
|
pipjon
|
159 |
47K |
0 |
27/09/22 |
27/09/22 |
ASX - By Stock
|
159
|
47K
|
0
|
|
ASX - By Stock
|
SPN |
Re:
Ann: Partnership Agreement with QUT Sustainable Battery Materials
|
|
pipjon
|
11 |
5.1K |
0 |
17/09/22 |
17/09/22 |
ASX - By Stock
|
11
|
5.1K
|
0
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
pipjon
|
20K |
7.0M |
3 |
15/09/22 |
15/09/22 |
ASX - By Stock
|
20K
|
7.0M
|
3
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
pipjon
|
10K |
3.7M |
2 |
24/04/22 |
24/04/22 |
General
|
10K
|
3.7M
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Preclinical & Clinical Programs Update
|
|
pipjon
|
26 |
10K |
22 |
31/03/22 |
31/03/22 |
ASX - By Stock
|
26
|
10K
|
22
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Expanded Heart Protection Discovery for Zantrene
|
|
pipjon
|
386 |
131K |
13 |
15/12/21 |
15/12/21 |
ASX - By Stock
|
386
|
131K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Expanded Heart Protection Discovery for Zantrene
|
|
pipjon
|
386 |
131K |
130 |
08/12/21 |
08/12/21 |
ASX - By Stock
|
386
|
131K
|
130
|
|